Off-label use of intravenous rifampicin during surgery: analysis of Australian surveillance data and retrospective audit at a tertiary hospital
Abstract Objective: To investigate the use of rifampicin vials in Australian operating theaters (OT) to determine the method of administration and rationale for use. Methods: Retrospective (2022 and 2023) OT usage data for rifampicin 600 mg vials were analyzed to compare trends in use between Au...
Saved in:
| Main Authors: | Nadine T. Hillock, Edward Raby, Matthew Rawlins |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-01-01
|
| Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X25000713/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis of Off-label Use of Intravenous Immunoglobulin in a Tertiary Health Care Facility: A Record-based Cross-sectional Study
by: Mitali Ganapati, et al.
Published: (2025-07-01) -
AUDIT QUALIFICATIONS AND GOVERNANCE CHARACTERISTICS: AUSTRALIAN EVIDENCE
by: Rusmin Rusmin
Published: (2016-01-01) -
The prevalence and consequences of support for off-label Ozempic prescriptions
by: Timothy Callaghan, et al. -
User perceptions of surgical antimicrobial prophylaxis guidelines in orthopaedic surgery in a tertiary Australian hospital.
by: Sarah Hassan, et al.
Published: (2025-01-01) -
List of diseases with off-label treatment
by: article Editorial
Published: (2022-05-01)